Orphan Drugs Market Analysis by Drug Type, Therapy Area &...

added blog Health

2026-07-27 05:58:28 -

Orphan Drugs Market Analysis by Drug Type, Therapy Area & Region, 2035

The Orphan Drugs Market features moderate concentration, with the top five players holding 35–42% of global revenue. Novartis leads with gene therapies like Zolgensma, while Roche anchors biologics innovation through Hemlibra and Evrysdi. Johnson & Johnson, Pfizer, and Sanofi maintain strong oncology and rare disease portfolios. Vertex Pharmaceuticals and CRISPR Therapeutics made...

0 Comments 0 Shares 195 Views 0 Reviews